|1.||Andres-Mach, Marta: 2 articles (12/2012 - 02/2010)|
|2.||Luszczki, Jarogniew J: 2 articles (12/2012 - 02/2010)|
|3.||Gengin, M T: 2 articles (09/2009 - 05/2002)|
|4.||Meiling-Wesse, Khuyen: 2 articles (01/2004 - 02/2002)|
|5.||Thumm, Michael: 2 articles (01/2004 - 02/2002)|
|6.||Florek-Luszczki, Magdalena: 1 article (12/2012)|
|7.||Barcicka-Klosowska, Beata: 1 article (12/2012)|
|8.||Haratym-Maj, Agnieszka: 1 article (12/2012)|
|9.||Zolkowska, Dorota: 1 article (12/2012)|
|10.||Dudra-Jastrzebska, Monika: 1 article (02/2010)|
04/01/1989 - "Further studies on the mechanism of the late protective effects of phenylmethylsulfonyl fluoride on carbon tetrachloride-induced liver necrosis."
05/01/1984 - "Late preventive effects of phenylmethylsulfonyl-fluoride on carbon tetrachloride-induced liver necrosis."
12/01/1983 - "Phenylmethylsulfonyl fluoride (PMSF) administration to rats, was effective in partially preventing liver necrosis induced by thioacetamide, dimethylnitrosamine or galactosamine, when given 6 hr after the hepatotoxins. "
12/01/1983 - "Late preventive effects on dimethylnitrosamine, thioacetamide or galactosamine-induced liver necrosis of the inhibitor of proteases, phenylmethylsulfonyl fluoride."
02/25/1996 - "To examine the mechanisms of activated PMN-mediated EC necrosis, the oxygen radical scavengers superoxide dismutase (SOD) and catalase, as well as the protease inhibitors phenylmethylsulfonyl fluoride (PMSF), alpha 1-antitrypsin (alpha 1-AT), soybean trypsin-chymotrypsin inhibitor (TCI), and aprotinin, were studied in coculture experiments. "
10/30/1985 - "Protection by acyl-carnitines and phenylmethylsulfonyl fluoride of rat heart subjected to ischemia and reperfusion."
08/01/1992 - "We examined the effect of phenylmethylsulfonyl fluoride, a phospholipase C inhibitor, on delayed neuronal damage after transient forebrain ischemia in the hippocampal CA1 subfield in rats to assess the role of phospholipase C in postischemic neuronal damage. "
10/30/1985 - "Perfusion of rat hearts according to the Langendorff technique with micromolar concentrations of palmitoylcarnitine or millimolar concentrations of phenylmethylsulfonyl fluoride protect the heart from deterioration by reperfusion after total-ischemia. "
04/01/1992 - "Phenylmethylsulfonyl fluoride inhibited the release of free fatty acids primarily from phosphatidylinositol during the first 2 minutes of ischemia and from phosphatidylcholine and phosphatidylethanolamine at 4 to 8 minutes of ischemia. "
06/01/1989 - "Immediately or after 24 hours of decapitation ischemia, the forebrain was removed and homogenized in 6 ml ice cold 0.05 M potassium phosphate buffer (pH 7.8) containing 1 mM phenylmethylsulfonyl fluoride, 0.3 mM EGTA, and 10 mM dithiothreitol. "
09/01/1997 - "Certain esterase inhibitors (such as phenylmethanesulfonyl fluoride, PMSF) enhance the clinical and morphological signs of organophosphate-induced delayed polyneuropathy (OPIDP) in hens. "
01/01/1992 - "It has been recently reported that phenylmethanesulfonyl fluoride (PMSF) when given to hens after a neuropathic organophosphate (OP) promotes organophosphate-induced delayed polyneuropathy (OPIDP). "
08/01/1991 - "Promotion of organophosphate-induced delayed polyneuropathy by phenylmethanesulfonyl fluoride."
04/01/1991 - "Promotion of organophosphate-induced delayed polyneuropathy by phenylmethanesulfonyl fluoride."
10/01/1996 - "Phenylmethanesulfonyl fluoride (PMSF) enhances the neuropathic response when given to hens after organophosphates causing delayed polyneuropathy. "
08/01/2004 - "Treatment of oocysts with these chemicals, along with the protease inhibitors, phenylmethylsulfonyl fluoride (PMSF), ethylenediamine-tetraacetic acid, and cystatin, inhibited protease activity as well as in vitro excystation and infection in a cell culture assay. "
10/30/1983 - "The enzyme denoted M protease was heat labile, was inhibited by the serine protease inhibitor phenylmethylsulfonyl fluoride, and its accumulation, which commenced between 2 and 3 hr after infection, required protein synthesis. "
01/01/1996 - "gingivalis W50 treated with 2 mM Na-P-tosyl-L-lysine chloromethyl ketone (TLCK)/phenylmethylsulfonyl fluoride (PMSF) prior to subcutaneous infection of mice failed to induce a phlegmonous abscess and lethality characteristic of animals challenged with untreated P. "
|1.||Carbon Tetrachloride (Tetrachloromethane)
|9.||Type C Phospholipases
|10.||Phospholipases A2 (Phospholipase A2)